HLA-G in organ transplantation;HLA-G en transplantation d'organes

Pathologie Biologie

Volumn 52, Issue 2, 2004, Pages 97-103

  Le Maoult, J ^a   Rouas Freiss, N ^a   Le Discorde, M ^a   Moreau, P ^a   Carosella, E D ^a,b  

^a Inst Univ d'Hématologie   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

Allogeneic; Allog nique; HLA; HLA G; Human leukocyte antigen; Inhibition; MHC; Natural killer; NK; Tolerance; Tol rance; Transplantation; Xenogeneic; X nog nique

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA G ANTIGEN;

ALLOIMMUNITY; ALLOTRANSPLANTATION; BIOPSY; CELL FUNCTION; CELL MIGRATION; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM; EXPERIMENTAL MODEL; FETUS (ANATOMY); GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MATURATION; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PATIENT MONITORING; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TISSUE TRANSPLANTATION; TRANSGENICS; XENOTRANSPLANTATION;

EID: 1542331694     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2003.04.006     Document Type: Article

References (51)

1. Kirszenbaum M., Djoulah S., Hors J., Le Gall I., de Oliveira E.B., Prost S., Dausset J., Carosella E.D. HLA-G gene polymorphism segregation within CEPH reference families. Hum Immunol. 53:1997;140-147.
2. Ishitani A., Kishida M., Sageshima N., Yashiki S., Sonoda S., Hayami M., Smith A.G., Hatake K. Re-examination of HLA-G polymorphism in African Americans. Immunogenetics. 49:1999;808-811.
3. Fujii T., Ishitani A., Geraghty D.E. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol. 153:1994;5516-5524.
4. Ishitani A., Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A. 89:1992;3947-3951.
5. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalil-Daher I., Vazeux G., Quiles R.M., Bermond F., Dausset J., Carosella E.D. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol. 61:2000;1138-1149.
6. Lee N., Malacko A.R., Ishitani A., Chen M.C., Bajorath J., Marquardt H., Geraghty D.E. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity. 3:1995;591-600.
7. Carosella E.D., Paul P., Moreau P., Rouas-Freiss N. HLA-G and HLA-E: fundamental and pathophysiological aspects. Immunol Today. 21:2000;532-534.
8. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., Angman L., Cella M., Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1803-1808.
9. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., Hsu M. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273-282.
10. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., Dunbar R., Ogg G.S., Cerundolo V., Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160:1998;3096-3100.
11. Ponte M., Cantoni C., Biassoni R., Tradori-Cappai A., Bentivoglio G., Vitale C., Bertone S., Moretta A., Moretta L., Mingari M.C. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A. 96:1999;5674-5679.
12. Rajagopalan S., Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. 189:1999;1093-1100.
13. Blaschitz A., Hutter H., Dohr G. HLA Class I protein expression in the human placenta. Early Pregnancy. 5:2001;67-69.
14. Crisa L., McMaster M.T., Ishii J.K., Fisher S.J., Salomon D.R. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med. 186:1997;289-298.
15. Yang Y., Chu W., Geraghty D.E., Hunt J.S. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol. 156:1996;4224-4231.
16. Moreau P., Adrian-Cabestre F., Menier C., Guiard V., Gourand L., Dausset J., Carosella E.D., Paul P. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol. 11:1999;803-811.
17. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol. 164:2000;6426-6434.
18. Aractingi S., Briand N., Le Danff C., Viguier M., Bachelez H., Michel L., Dubertret L., Carosella E.D. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol. 159:2001;71-77.
19. Lila N., Carpentier A., Amrein C., Khalil-Daher I., Dausset J., Carosella E.D. Implication of HLA-G molecule in heart-graft acceptance. Lancet. 355:2000;2138.
20. Rouas-Freiss N., Marchal R.E., Kirszenbaum M., Dausset J., Carosella E.D. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A. 94:1997;5249-5254.
21. Khalil-Daher I., Riteau B., Menier C., Sedlik C., Paul P., Dausset J., Carosella E.D., Rouas-Freiss N. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol. 43:1999;175-182.
22. Navarro F., Llano M., Bellon T., Colonna M., Geraghty D.E., Lopez-Botet M. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol. 29:1999;277-283.
23. Menier C., Riteau B., Dausset J., Carosella E.D., Rouas-Freiss N. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol. 61:2000;1118-1125.
24. Riteau B., Menier C., Khalil-Daher I., Martinozzi S., Pla M., Dausset J., Carosella E.D., Rouas-Freiss N. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol. 13:2001;193-201.
25. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci United-States. 94:1997;11520-11525.
26. Marchal-Bras-Goncalves R., Rouas-Freiss N., Connan F., Choppin J., Dausset J., Carosella E.D., Kirszenbaum M., Guillet J. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc. 33:2001;2355-2359.
27. Le Gal F.A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., Guillet J.G., Carosella E.D., Rouas-Freiss N. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol. 11:1999;1351-1356.
28. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol. 166:2001;5018-5026.
29. Kapasi K., Albert S.E., Yie S., Zavazava N., Librach C.L. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 101:2000;191-200.
30. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., Bensussan A., Le Bouteiller P. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol. 164:2000;6100-6104.
31. Riteau B., Menier C., Khalil-Daher I., Sedlik C., Dausset J., Rouas-Freiss N., Carosella E.D. HLA-G inhibit the allogeneic proliferative response. J Reprod Immunol. 43:1999;203-211.
32. Bainbridge D.R., Ellis S.A., Sargent I.L. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol. 48:2000;17-26.
33. Lila N., Rouas-Freiss N., Dausset J., Carpentier A., Carosella E.D. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A. 98:2001;12150-12155.
34. Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., Dausset J., Carosella E.D., Carpentier A. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation. 105:2002;1949-1954.
35. Rasmussen A., Davies H., Jamieson N., Evans D., Calne R. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation. 59:1995;919-921.
36. Hiesse C., Samuel D., Chraibi A., Bensadoun H., Blanchet P., Bellamy J., Charpentier B., Bismuth H. Combined liver and kidney transplantation in nephropathy associated with liver disease. Transplant Proc. 27:1995;1262-1263.
37. Créput C., Durrbach A., Menier C., Guettier C., Samuel D., Dausset J., Charpentier B., Carosella E., Rouas-Freiss N. HLA-G expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. 2003;. Submitted for publication.
38. Cortesini R., LeMaoult J., Ciubotariu R., Cortesini N.S. CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol Rev. 182:2001;201-206.
39. Ciubotariu R., Vasilescu R., Ho E., Cinti P., Cancedda C., Poli L., Late M., Liu Z., Berloco P., Cortesini R., Suciu-Foca Cortesini N. Detection of T suppressor cells in patients with organ allografts. Hum Immunol. 62:2001;15-20.
40. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., Lederman S., Colonna M., Cortesini R., Dalla-Favera R., Suciu-Foca N. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol. 3:2002;237-243.
41. Le Discorde M., Moreau P., Legeais J., Sabatier P., Carosella E. Expression of HLA-G in human cornea, an immune-privileged tissue. 2003;. Submitted for publication.
42. Waldock A., Cook S.D. Corneal transplantation: how successful are we? Br J Ophthalmol. 84:2000;813-815.
43. Inverardi L., Pardi R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev. 141:1994;71-93.
44. Sasaki H., Xu X.C., Smith D.M., Howard T., Mohanakumar T. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Transplantation. 67:1999;31-37.
45. Sasaki H., Xu X.C., Mohanakumar T. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways. J Immunol. 163:1999;6301-6305.
46. Forte P., Pazmany L., Matter-Reissmann U.B., Stussi G., Schneider M.K., Seebach J.D. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J Immunol. 167:2001;6002-6008.
47. Forte P., Matter-Reissmann U.B., Strasser M., Schneider M.K., Seebach J.D. Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity. Hum Immunol. 61:2000;1066-1073.
48. Matsunami K., Miyagawa S., Nakai R., Murase A., Shirakura R. The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis. Clin Exp Immunol. 126:2001;165-172.
49. Dorling A., Monk N.J., Lechler R.I. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol. 30:2000;586-593.
50. Horuzsko A., Lenfant F., Munn D.H., Mellor A.L. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol. 13:2001;385-394.
51. Liang S., Baibakov B., Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol. 32:2002;2418-2426.